{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:13:47Z","timestamp":1792977227080,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"United States Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response","award":["5 U3REP170552-003-02"],"award-info":[{"award-number":["5 U3REP170552-003-02"]}],"id":[{"id":"https:\/\/ror.org\/033jnv181","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ijid.2020.07.042","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T11:23:38Z","timestamp":1596453818000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"special_numbering":"C","title":["Marburg virus disease: A summary for clinicians"],"prefix":"10.1016","volume":"99","author":[{"given":"Mark G.","family":"Kortepeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dierberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Cieslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.07.042_bib0005","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/1469-0691.12673","article-title":"Marburg haemorrhagic fever in returning travellers: an overview aimed at clinicians","volume":"21","author":"Bauer","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2020.07.042_bib0010","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2013 preliminary report","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.12.021","article-title":"Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus","volume":"151","author":"Bixler","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.ijid.2020.07.042_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3201\/eid1203.050622","article-title":"Serosurvey on household contacts of Marburg hemorrhagic fever patients","volume":"12","author":"Borchert","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0025","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/v4101878","article-title":"Forty-five years of Marburg virus research","volume":"4","author":"Brauburger","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2020.07.042_bib0030","series-title":"A rational approach to disinfection and sterilization: guideline for disinfection and sterilization in healthcare facilities","author":"CDC","year":"2008"},{"key":"10.1016\/j.ijid.2020.07.042_bib0035","series-title":"Marburg hemorrhagic fever (Marburg HF)","author":"CDC","year":"2019"},{"key":"10.1016\/j.ijid.2020.07.042_bib0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.chom.2018.08.003","article-title":"Persistent Marburg virus infection in the testes of nonhuman primate survivors","volume":"24","author":"Coffin","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijid.2020.07.042_bib0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrd.2017.251","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","volume":"17","author":"Cross","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijid.2020.07.042_bib0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2020.07.042_bib0055","first-page":"171","article-title":"First newborn baby to receive experimental therapies survives Ebola virus disease","volume":"215","author":"Dornemann","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2017.03.003","article-title":"How to treat Ebola virus infections? A lesson from the field","volume":"24","author":"Duraffour","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ijid.2020.07.042_bib0065","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ijid.2020.07.042_bib0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/erv.10.152","article-title":"Progress in filovirus vaccine development: evaluating the potential for clinical use","volume":"10","author":"Falzarano","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2020.07.042_bib0075","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMp1817070","article-title":"Shifting the paradigm \u2013 applying universal standards of care to Ebola virus disease","volume":"380","author":"Fischer","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/bmj.4.5995.489","article-title":"Outbreak of Marburg virus disease in Johannesburg","volume":"4","author":"Gear","year":"1975","journal-title":"Br Med J"},{"issue":"52","key":"10.1016\/j.ijid.2020.07.042_bib0085","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses","volume":"26","author":"Geisbert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2020.07.042_bib0090","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J. Virol"},{"issue":"19","key":"10.1016\/j.ijid.2020.07.042_bib0095","doi-asserted-by":"crossref","first-page":"10386","DOI":"10.1128\/JVI.00594-10","article-title":"Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates","volume":"84","author":"Geisbert","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2020.07.042_bib0100","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3201\/eid1607.100159","article-title":"Postexposure treatment of Marburg virus infections","volume":"16","author":"Geisbert","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0105","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2020.07.042_bib0110","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1128\/AAC.03442-14","article-title":"Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against Ebola virus and Marburg virus: results of two single-ascending-dose studies","volume":"58","author":"Heald","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.07.042_bib0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa1410345","article-title":"AVI-7299 for Marburg virus in nonhuman primates and humans","volume":"373","author":"Heald","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2020.07.042_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00177-17","article-title":"A polymorphism within the internal fusion loop of the Ebola virus glycoprotein modulates host cell entry","volume":"91","author":"Hoffmann","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2020.07.042_bib0130","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1086\/520611","article-title":"Cytokine and chemokine expression in humans infected with Sudan Ebola virus","volume":"196","author":"Hutchinson","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0135","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/v4112806","article-title":"Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections","volume":"4","author":"Iversen","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2020.07.042_bib0140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","article-title":"Late Ebola virus relapse causing meningoencephalitis: a case report","volume":"388","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2020.07.042_bib0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ijid.2020.07.042_bib0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/jiz078","article-title":"Laboratory findings, compassionate use of favipiravir, and outcome in patients with Ebola virus disease, Guinea, 2015 \u2013a retrospective observational study","volume":"220","author":"Kerber","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0155","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/infdis\/jir299","article-title":"Basic clinical and laboratory features of human filoviral fever","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bjo.61.4.265","article-title":"Uveal involvement in Marburg virus disease","volume":"61","author":"Kuming","year":"1977","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ijid.2020.07.042_bib0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14760584.7.2.175","article-title":"Current progress of DNA vaccine studies in humans","volume":"7","author":"Lu","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2020.07.042_bib0170","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/CVI.00162-06","article-title":"A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijid.2020.07.042_bib0175","series-title":"Marburg virus disease","first-page":"1","article-title":"Marburg virus disease. Clinical syndrome","author":"Martini","year":"1971"},{"key":"10.1016\/j.ijid.2020.07.042_bib0180","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/pgmj.49.574.542","article-title":"Marburg virus disease","volume":"49","author":"Martini","year":"1973","journal-title":"Postgrad Med J"},{"issue":"15","key":"10.1016\/j.ijid.2020.07.042_bib0185","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored Ebola vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2020.07.042_bib0190","doi-asserted-by":"crossref","first-page":"e94355","DOI":"10.1371\/journal.pone.0094355","article-title":"Durability of a vesicular stomatitis virus-based Marburg virus vaccine in nonhuman primates","volume":"9","author":"Mire","year":"2014","journal-title":"PLoS One"},{"issue":"384","key":"10.1016\/j.ijid.2020.07.042_bib0195","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8711","article-title":"Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody","volume":"9","author":"Mire","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0200","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0205","series-title":"Vaccines in healthy volunteers","author":"MVA-BN\u00ae-Filo","year":"2020"},{"key":"10.1016\/j.ijid.2020.07.042_bib0210","series-title":"Home \u2013 MeSH \u2013 NCBI","author":"National Center for Biotechnology Information","year":"2019"},{"key":"10.1016\/j.ijid.2020.07.042_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.17573.1","article-title":"Recent advances in marburgvirus research","volume":"8","author":"Olejnik","year":"2019","journal-title":"F1000Research"},{"key":"10.1016\/j.ijid.2020.07.042_bib0220","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/1756-0500-7-906","article-title":"Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease","volume":"7","author":"Pavlin","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijid.2020.07.042_bib0225","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa290","article-title":"Remdesivir (GS-5734) is efficacious in cynomolgus macaques infected with Marburg virus","author":"Porter","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11262-017-1455-x","article-title":"Ebola and Marburg virus vaccines","volume":"53","author":"Reynolds","year":"2017","journal-title":"Virus Genes"},{"issue":"25\u201326","key":"10.1016\/j.ijid.2020.07.042_bib0235","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2020.07.042_bib0240","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1086\/520613","article-title":"Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus","volume":"196","author":"Rollin","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcv.2015.01.014","article-title":"Ebola and Marburg hemorrhagic fever","volume":"64","author":"Rougeron","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijid.2020.07.042_bib0250","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Clinical illness and outcomes in patients with Ebola in Sierra Leone","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijid.2020.07.042_bib0255","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0260","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/infdis\/jis921","article-title":"Interferon-beta therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever","volume":"208","author":"Smith","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0265","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0270","series-title":"Marburg virus disease","first-page":"10","article-title":"Clinical course and prognosis of Marburg virus (\u201cgreen monkey\u201d) disease","author":"Stille","year":"1971"},{"key":"10.1016\/j.ijid.2020.07.042_bib0275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00431-07","article-title":"Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections","volume":"15","author":"Swenson","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijid.2020.07.042_bib0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.7.4.417","article-title":"Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses","volume":"7","author":"Swenson","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2020.07.042_bib0285","doi-asserted-by":"crossref","first-page":"ra116","DOI":"10.1126\/scitranslmed.3009706","article-title":"Marburg virus infection in nonhuman primates: therapeutic treatment by lipid-encapsulated siRNA","volume":"6","author":"Thi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0290","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/infdis\/jit465","article-title":"Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA","volume":"209","author":"Ursic-Bedoya","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.ijid.2020.07.042_bib0295","doi-asserted-by":"crossref","first-page":"S1053","DOI":"10.1093\/infdis\/jir346","article-title":"Advances in virus-like particle vaccines for filoviruses","volume":"204","author":"Warfield","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2020.07.042_bib0300","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2020.07.042_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004456","article-title":"Delayed time to treatment of an antisense morpholino oligomer is effective against lethal Marburg virus infection in cynomolgus macaques","volume":"10","author":"Warren","year":"2016","journal-title":"PLoS Neglect Trop Dis"},{"issue":"13","key":"10.1016\/j.ijid.2020.07.042_bib0310","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJMc1415318","article-title":"Ebola virus disease among children in West Africa","volume":"372","author":"WHO Ebola Response Team","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.07.042_bib0315","doi-asserted-by":"crossref","first-page":"S582","DOI":"10.1093\/infdis\/jiy293","article-title":"Postexposure efficacy of recombinant vesicular stomatitis virus vectors against high and low doses of Marburg virus variant Angola in nonhuman primates","volume":"218","author":"Woolsey","year":"2018","journal-title":"J Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220305865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220305865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:53:10Z","timestamp":1761119590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220305865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":63,"alternative-id":["S1201971220305865"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.07.042","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marburg virus disease: A summary for clinicians","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}